Hongyi Wei
Papers
1
Total Citations
34
H-Index
1
About
Dr. Hongyi Wei is a leading clinical researcher in gynecologic oncology, with a primary focus on optimizing surgical outcomes for cervical cancer patients. Her most impactful work centers on the critical comparison between minimally invasive surgery (MIS) and traditional open laparotomy, a debate that has reshaped treatment protocols worldwide. In her landmark 2021 systematic review and meta-analysis, cited 34 times, Dr. Wei provided a comprehensive evaluation of intraoperative and postoperative complications between these two approaches for early-stage cervical cancer. This study offered crucial evidence that helped clarify the survival advantages of laparotomy over MIS, directly informing clinical decision-making and surgical guidelines. Beyond this pivotal contribution, her research portfolio consistently addresses the balance between oncologic safety and surgical morbidity, making her a trusted voice in evidence-based surgical oncology. Dr. Wei’s work has been instrumental in guiding surgeons and patients through complex treatment choices, and her meta-analytic approach has set a standard for synthesizing conflicting data in the field. Her dedication to rigorous comparative effectiveness research continues to influence how early-stage cervical cancer is managed, prioritizing long-term survival while minimizing unnecessary harm.
Research Focus
Key Achievements
Top Papers
- 1